文献速递外周血管技术与安全CTMR

微小型猪淋巴结内动态增强CT与MR淋巴管造影的可行性研究

Intranodal dynamic contrast-enhanced CT lymphangiography and dynamic contrast-enhanced MR lymphangiography in microminipig.
PubMed 文献 · Eur Radiol · 2023-02-23

本研究在3只微小型猪中评估淋巴结内动态增强CT淋巴管造影(DCCTL)和动态增强MR淋巴管造影(DCMRL)的可行性与图像质量。结果显示两种方法均能良好显示中央淋巴管及淋巴漏,DCCTL的对比增强指数在5-10分钟达峰,DCMRL的信号强度比在2-4或4-10分钟达峰,提示两者具有研究和临床潜力。

要点

  • DCCTL与DCMRL均可清晰显示中央淋巴管及淋巴漏。
  • DCCTL对比增强峰值时间为5-10分钟,DCMRL为2-4或4-10分钟。
  • 上中部胸导管可见性和连续性评分均较高。

关键影像表现/征象

  • DCCTL上静脉角、上胸导管和中胸导管的峰值对比增强指数分别为235.6 HU、239.4 HU和387.3 HU。
  • DCMRL上静脉角、上胸导管和中胸导管的峰值信号强度比分别为4.8、2.1和2.1。
  • DCCTL上中部胸导管可见性评分为4.0,连续性评分为3.3-3.7;DCMRL两者均为4.0。
  • 在淋巴管损伤模型中,DCCTL和DCMRL均能显示淋巴漏。

诊断标准与关键数值

  • 形态可读性、可见性和连续性采用4分制评分。
  • 对比增强指数定义为增强前后CT值增加量;信号强度比定义为淋巴信号强度除以肌肉信号强度。

临床应用与阅片要点

  • 阅片时DCCTL应关注注射后5-10分钟达峰的对比增强,DCMRL关注2-4或4-10分钟的信号峰值。
  • 评估中央淋巴管时注意上中部胸导管的可见性和连续性,两种方法评分均较高。
  • 怀疑淋巴漏时,DCCTL和DCMRL均可作为检测手段。

局限性

  • 样本量小(3只微小型猪),结论需进一步验证。
  • 为动物实验研究,临床转化需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the feasibility and image quality of intranodal dynamic contrast-enhanced CT lymphangiography (DCCTL) and dynamic contrast-enhanced MR lymphangiography (DCMRL) in microminipigs.

METHODS: Our institution's committee for animal research and welfare provided approval. Three microminipigs underwent DCCTL and DCMRL after inguinal lymph node injection of 0.1 mL/kg contrast media. Mean CT values on DCCTL and signal intensity (SI) on DCMRL were measured at the venous angle and thoracic duct (TD). The contrast enhancement index (CEI; increase in CT values pre- to post-contrast) and signal intensity ratio (SIR; SI of lymph divided by SI of muscle) were evaluated. The morphologic legibility, visibility, and continuity of lymphatics were qualitatively evaluated using a 4-point scale. Two microminipigs underwent DCCTL and DCMRL after lymphatic disruption and the detectability of lymphatic leakage was evaluated.

RESULTS: The CEI peaked at 5-10 min in all microminipigs. The SIR peaked at 2-4 min in two microminipigs and at 4-10 min in one microminipig. The peak CEI and SIR values were 235.6 HU and 4.8 for venous angle, 239.4 HU and 2.1 for upper TD, and 387.3 HU and 2.1 for middle TD. The visibility and continuity of upper-middle TD scores were 4.0 and 3.3-3.7 for DCCTL, and 4.0 and 4.0 for DCMRL. In the injured lymphatic model, both DCCTL and DCMRL demonstrated lymphatic leakage.

CONCLUSIONS: DCCTL and DCMRL in a microminipig model enabled excellent visualization of central lymphatic ducts and lymphatic leakage, indicating the research and clinical potential of both modalities.

KEY POINTS: • Intranodal dynamic contrast-enhanced computed tomography lymphangiography showed a contrast enhancement peak at 5-10 min in all microminipigs. • Intranodal dynamic contrast-enhanced magnetic resonance lymphangiography showed a contrast enhancement peak at 2-4 min in two microminipigs and at 4-10 min in one microminipig. • Both intranodal dynamic contrast-enhanced computed tomography lymphangiography and dynamic contrast-enhanced magnetic resonance lymphangiography demonstrated the central lymphatic ducts and lymphatic leakage.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Tanahashi, Shoda, Kawada, et al. Intranodal dynamic contrast-enhanced CT lymphangiography and dynamic contrast-enhanced MR lymphangiography in microminipig. Eur Radiol. 2023. PMID: 36814031. doi:10.1007/s00330-023-09463-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。